EU throws weight behind Pfizer-BioNTech and new technology

In a stinging rebuke to pharma giant AstraZeneca, the European Union on Wednesday announced plans to negotiate a massive contract extension for Pfizer-BioNTech's Covid-19 vaccine insisting the 27-nation bloc had to go with companies that had shown their value in the pandemic. "We need to focus on technologies that have proven their worth," said EU Commission President Ursula von der Leyen.
Read more...

;